IP Library › Granted Patent US 10,368,896
Granted Patent B2
US 10,368,896 · App. 15/269,175 · Granted Aug 6, 2019

Treatment device

Inventor: Tsunetaka Akagane (Hachioji, JP)
Assignee: OLYMPUS CORPORATION
A61B17/320068A61B18/00A61B18/12A61N7/02A61B2018/00083A61B2018/00107A61B2018/00607A61B2018/00994A61B2018/1412
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,368,896
App. No.
15/269,175
Granted
Aug 6, 2019
Kind
B2
Abstract

A treatment device includes, a probe that conveys ultrasonic vibration and a high-frequency current; a treatment section that comprises a first treatment surface provided at a distal end of the probe for treating body tissue and a second treatment surface opposed to the first treatment surface, and treats the body tissue with the ultrasonic vibration and the high-frequency current conveyed to the first treatment surface and the second treatment surface via the probe; and an electrically-insulating coating portion that covers at least one of the first treatment surface and the second treatment surface.

Claims (32)

1. A treatment device for use with body tissue, the treatment device comprising:

an ultrasonic transducer configured to generate ultrasonic vibration;

a probe configured to transmit the ultrasonic vibration and a high-frequency current;

a treatment section at a distal end of the probe, the treatment section having a first treatment surface and a second treatment surface, and the treatment section being configured to treat the body tissue with the ultrasonic vibration and the high-frequency current that is transmitted to the first treatment surface and the second treatment surface via the probe,

the second treatment surface including:

a plain portion opposed to the first treatment surface,

a concave portion adjacent to the plain portion in a distal end direction, the concave portion being concave towards the first treatment surface and forming a profile of cylinder extending in a direction intersecting a longitudinal direction of the probe, and

an edge portion adjacent to the concave portion in the distal end direction and being exposed to allow the high-frequency current to electrically flow;

an electrically-insulating coating portion covering the plain portion and the concave portion of the second treatment surface; and

an outer peripheral portion corresponding to a side surface of the treatment section positioned between the first treatment surface and the second treatment surface, is exposed to allow the high-frequency current to electrically flow to the body tissue such that the body tissue is treated with the high-frequency current, wherein

the concave portion has a half-cylinder shape extending in a direction intersecting a longitudinal axis of a probe main body of the probe.

2. The treatment device of claim 1 , further comprising:

a neck portion provided between a probe main body and the treatment section and having a dimension smaller than that of the treatment section with respect to a width direction intersecting a longitudinal axis of the probe main body, wherein

the electrically-insulating coating portion covers the neck portion and the probe main body.

3. The treatment device of claim 1 , wherein the electrically-insulating coating portion covers at least a part of the outer peripheral portion.

4. The treatment device of claim 1 , wherein the electrically-insulating coating portion covers the first treatment surface.

5. The treatment device of claim 1 , wherein the treatment section is shaped like a spoon or spatula.

6. The treatment device of claim 1 , wherein the edge portion is elevated from the concave portion of the second treatment surface in a direction away from the first treatment surface.

7. A treatment device comprising:

an ultrasonic transducer configured to generate ultrasonic vibration;

a probe configured to transmit ultrasonic vibration and a high-frequency current;

a treatment section having: (A) a first treatment surface provided at a distal end of the probe, and (B) a second treatment surface, the treatment section being configured to treat the body tissue with the ultrasonic vibration and the high-frequency current that is transmitted to the first treatment surface and the second treatment surface via the probe,

the first treatment surface and the second treatment surface being plates opposed to each other,

the second treatment surface including:

a plain portion opposed to the first treatment surface,

a concave portion adjacent to the plain portion in a distal end direction, the concave portion being concave towards the first treatment surface and forming a profile of cylinder extending in a direction intersecting a longitudinal direction of the probe, and

an edge portion adjacent to the concave portion in the distal end direction and being exposed to allow the high-frequency current to electrically flow;

a neck portion provided between a probe main body of the probe and the treatment section and having a dimension smaller than that of the treatment section with respect to a width direction intersecting a longitudinal axis of the probe main body;

an electrically-insulating coating portion covering the first treatment surface and the plain portion and the concave portion of the second treatment surface as well as the neck portion and the probe main body; and

an outer peripheral portion forming a side surface of the treatment section between the first treatment surface and the second treatment surface, the outer peripheral portion being exposed to allow high-frequency current to electrically flow to the body tissue such that the body tissue is treated with the high-frequency current, wherein

the concave portion has a half-cylinder shape extending in a direction intersecting a longitudinal axis of a probe main body of the probe.

8. The treatment device of claim 7 , wherein the edge portion is elevated from the concave portion of the second treatment surface in a direction away from the first treatment surface.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2016
From: AKAGANE, TSUNETAKA
To: OLYMPUS CORPORATION
Reel/Frame 039781/0488 →
Priority Claims (1)
JP 2014-107512 · May 23, 2014 · national
Continuity (2)
Continuation PCTJP2015063762 · May 13, 2015
Related Publication 20170000515A1 · Jan 5, 2017
Cited By (2)
US 12,213,717 US 12,232,791